Pub­lic funds help late-stage de­vel­op­ment of about 25% of new drugs, study finds

One in four new drugs ap­proved in the US be­tween Jan­u­ary 2008 and De­cem­ber 2017 re­ceived di­rect fund­ing from pub­lic re­sources for late stage re­search …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.